22/07/2026 - General information
Dr Arnau Busquets, coordinator of the Cellular Mechanisms in Physiological and Pathological Behaviour Research Group at the Hospital del Mar Research Institute (HMRIB), has been elected to the Executive Committee of the European Brain and Behaviour Society (EBBS), the governing body of one of Europe's leading scientific societies dedicated to research on animal models and behaviour. The election took place on 21 May.
15/07/2026 - General information
Dr Sara Mederos and Dr Manuel Valero, coordinators of the Neural Computation Laboratory at the Hospital del Mar Research Institute (HMRIB), have been appointed as members of the first cohort of Young Ambassadors of the Spanish Society for Neuroscience (SENC). This distinction recognises outstanding early-career researchers in the field of neuroscience who have already demonstrated remarkable international achievements, scientific independence, and a strong commitment to strengthening the Spanish neuroscience community.
14/07/2026 - Press release
People who experienced traumatic events during childhood are 1.5 times more likely to develop physical illnesses than the general population. The association is strongest in cases of bullying, physical or sexual abuse, and parental loss or abandonment, according to a study led by the Hospital del Mar Research Institute that analyzed data from 250 published studies on the subject up to April 2025. The findings may help draw attention to the possible causes of a wide range of physical diseases and reinforce efforts to prevent childhood trauma
Més informació "Childhood Trauma Linked to Higher Risk of Developing Physical Disease"
07/07/2026 - General information
He is one of the fifteen researchers selected to take part in this initiative. Over the next two years, he will collaborate in a network focused on advancing neuroscience through scientific exchange, awareness-raising and outreach. Dr Manuel Valero, coordinator of the Neural Computation Laboratory at the Hospital del Mar Research Institute, is one of the fifteen young neuroscientists selected to join the FENS-Kavli Scholars network, an initiative integrated into the Kavli Network of Excellence of the Federation of European Neuroscience Societies (FENS). From twelve European countries, they join the researchers selected in 2023 to promote neuroscience research through a range of actions.
01/07/26 - General information
The Hospital del Mar Research Institute has presented its new Impact Department, a cross-cutting structure created to strengthen the centre's capacity to generate, measure, transfer and communicate the impact of research and innovation to society. Its creation responds to the evolution of the research and innovation system and to the growing importance that organisations such as CERCA, the ISCIII, AQuAS and other stakeholders in the sector place on the generation and demonstration of impact. This comes in a context in which research centres must go beyond scientific excellence and be able to demonstrate the value their activity brings to patients, the healthcare system and society.
Més informació "HMRIB launches its Impact Department to promote the social return of research"
02/07/26 - General information
The project involves the launch of IAM-CAT, an integrated registry of acute myocardial infarction that aims to improve planning and epidemiological surveillance, quality of care and research in cardiovascular health. The IAM-CAT project, led by the Hospital del Mar Research Institute (HMRIB) and Hospital del Mar, has received the Bronze Award at the National Health System (SNS) Good Practices Conference, held on 9 June. The conference aims to identify and disseminate good practices that contribute to the sustainability of the SNS through the exchange of experiences and knowledge transfer among the health services of Spain's autonomous communities.
29/06/2026 - General information
An international consortium led by the Hospital del Mar Research Institute (HMRIB) and Hospital del Mar, within the International Stroke Genetics Consortium, has identified two genetic variants that may be responsible for one of the most serious complications following aneurysmal subarachnoid haemorrhage (aSAH), a type of stroke associated with poor outcomes that predominantly affects young women. The study, published in Brain, shows that the COL6A6 and PIK3R4 genes may be linked to an increased risk of delayed cerebral ischaemia, a complication that affects approximately one in four patients diagnosed with this condition.
Més informació "Genetics behind one of the main complications following subarachnoid haemorrhage"
25/06/2026 - General information
Dr. Toni Celià-Terrassa, Principal Investigator and Head of the Cancer Cell States and Metastatic Immunity Research Group at the Hospital del Mar Research Institute (HMRIB), has been awarded one of the European Union's prestigious ERC Advanced Grants. The grant provides €2.5 million to develop a project focused on generating new therapeutic strategies for breast cancer. The project, named PLASTWIRE (Re-wiring Tumor Immune-Evasive Plasticity with mRNA Therapy), will explore over the next five years the possibility of modifying the immune-evasive cellular states of tumour cells. Tumour heterogeneity is one of the main drivers of treatment resistance and therapeutic failure.
22/06/2026 - General information
Ayahuasca is a powerful Amazonian brew known to induce profound effects, including the so-called ego dissolution-a temporary alteration in the usual sense of self or personal identity. But how does it produce these effects? An international study led by the Applied Metabolomics Research Group at the Hospital del Mar Research Institute (HMRIB) has shown that the experience arises through a complex coordination between the body, the brain, and consciousness itself. The findings have been published in Biomedicine & Pharmacotherapy. Researchers from Maastricht University in the Netherlands and Goethe University Frankfurt in Germany also participated in the study.
18/06/2026 - Press release
A study in mice by the Hospital del Mar Research Institute and the IIBB-CSIC, published in Science Advances, identifies inhibition of the PARP2 protein as a therapeutic target for treating pancreatic cancer, the third leading cause of cancer death worldwide. The study analyses the role of this protein in tumour development and protection, and describes how its elimination leads to tumour cell death and activation of the immune system. Specifically blocking this protein may be a useful strategy for treating a large number of patients with pancreatic cancer and could even be applicable to other types of tumours.
Servei de Comunicació:
Marta Calsina(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
